Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Patched1 functions as a gatekeeper by promoting cell cycle progression.

Christelle Adolphe1, Rehan Hetherington, Tammy Ellis

  • 1Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.

Cancer Research
|February 21, 2006
PubMed
Summary

Loss of Patched 1 (Ptch1) function in mouse skin basal cells drives rapid skin tumor formation, similar to human basal cell carcinoma (BCC). This suggests Ptch1 acts as a tumor suppressor by regulating cell cycle progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Childhood brain tumors instruct cranial hematopoiesis and immunotolerance.

Nature genetics·2026
Same author

Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic target.

Cancer cell·2025
Same author

Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179.

Nature communications·2025
Same author

"If you build it, they will come": the convergence of funding, research and collaboration in paediatric brain cancer clinical trials.

The Medical journal of Australia·2024
Same author

Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179.

Research square·2023
Same author

SOX9 Defines Distinct Populations of Cells in SHH Medulloblastoma but Is Not Required for Math1-Driven Tumor Formation.

Molecular cancer research : MCR·2021

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Mutations in the Hedgehog receptor, Patched 1 (Ptch1), are implicated in basal cell carcinoma (BCC).
  • Loss of Ptch1 function is hypothesized to be sufficient for BCC development.

Purpose of the Study:

  • To investigate if loss of Ptch1 function in basal cells is sufficient for skin tumor formation in vivo.
  • To elucidate the molecular mechanisms by which Ptch1 loss drives tumor progression.

Main Methods:

  • Utilized conditional knockout technology in mice.
  • Employed inducible Keratin6 promoter activity to target basal cell populations.
  • Analyzed beta-catenin translocation, Notch pathway activation, and cell cycle regulator expression.

Related Experiment Videos

Main Results:

  • Loss of Ptch1 in mouse skin basal cells induced rapid tumor formation resembling human BCC.
  • Ptch1 elimination did not affect beta-catenin nuclear translocation or Notch pathway activation.
  • Absence of Ptch1 led to nuclear accumulation of cyclin D1 and B1, cell cycle regulators.

Conclusions:

  • Ptch1 functions as a tumor suppressor by inhibiting cell cycle progression at G1-S and G2-M phases.
  • Ptch1 acts as a "gatekeeper" in preventing skin tumor development.
  • This mouse model is valuable for testing therapeutic strategies targeting the Patched pathway.